Institutions / Vivo Capital, LLC
Vivo Capital, LLC
CIK 1674712 · Institution · as of Dec 31, 2025
Portfolio value
$1.55B
Positions
47
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 47 →
| Company | Value | % of portfolio |
|---|---|---|
| Terns Pharmaceuticals, Inc. | $216.02M | 14.0% |
| Cidara Therapeutics, Inc. | $211.32M | 13.7% |
| Praxis Precision Medicines, Inc. | $96.94M | 6.3% |
| Cogent Biosciences, Inc. | $85.21M | 5.5% |
| Trevi Therapeutics, Inc. | $63.79M | 4.1% |
| Avadel Pharmaceuticals PLC | $57.84M | 3.7% |
| Compass Therapeutics, Inc. | $51.26M | 3.3% |
| Dyne Therapeutics, Inc. | $51.15M | 3.3% |
| Abivax SA - ADR | $48.45M | 3.1% |
| Dbv Technologies S.A.DBVT | $47.19M | 3.1% |
| SAB Biotherapeutics, Inc. | $42.71M | 2.8% |
| Soleno Therapeutics, Inc. | $41.43M | 2.7% |
| Bright Minds Biosciences Inc. | $39.15M | 2.5% |
| Sinovac Biotech Ltd. | $38.19M | 2.5% |
| Geron Corp | $35.94M | 2.3% |
| Erasca, Inc.ERAS | $34.50M | 2.2% |
| Zenas BioPharma, Inc.ZBIO | $30.99M | 2.0% |
| Viridian Therapeutics, Inc. | $30.58M | 2.0% |
| Aclaris Therapeutics, Inc. | $26.76M | 1.7% |
| Camp4 Therapeutics Corp | $26.03M | 1.7% |
| Tango Therapeutics, Inc. | $19.09M | 1.2% |
| Alto Neuroscience, Inc.ANRO | $18.43M | 1.2% |
| Lb Pharmaceuticals IncLBRX | $17.81M | 1.2% |
| Minerva Neurosciences, Inc. | $17.38M | 1.1% |
| Oric Pharmaceuticals, Inc. | $17.33M | 1.1% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.